Jason Ehrlich
2021
In 2021, Jason Ehrlich earned a total compensation of $27.9M as Chief Medical Officer and Chief Development Officer at Kodiak Sciences, a 814% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $254,948 |
---|---|
Option Awards | $25,844,150 |
Salary | $479,000 |
Stock Awards | $1,323,150 |
Other | $45,303 |
Total | $27,946,551 |
Ehrlich received $25.8M in option awards, accounting for 92% of the total pay in 2021.
Ehrlich also received $254.9K in non-equity incentive plan, $479K in salary, $1.3M in stock awards and $45.3K in other compensation.
Rankings
In 2021, Jason Ehrlich's compensation ranked 174th out of 12,415 executives tracked by ExecPay. In other words, Ehrlich earned more than 98.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 174 | 99th |
Manufacturing | 46 | 99th |
Chemicals And Allied Products | 16 | 99th |
Drugs | 12 | 99th |
Biological Products, Except Diagnostic Substances | 8 | 98th |
Ehrlich's colleagues
We found two more compensation records of executives who worked with Jason Ehrlich at Kodiak Sciences in 2021.
News
Kodiak Sciences CEO Victor Perlroth's 2023 pay slips 9% to $2.7M
April 23, 2024
Kodiak Sciences CEO Victor Perlroth's 2022 pay falls 97% to $3M
April 25, 2023
Kodiak Sciences CEO Victor Perlroth's 2020 pay falls 49% to $8.9M
April 28, 2021
Kodiak Sciences CEO Victor Perlroth's 2019 pay jumps 199% to $18M
April 28, 2020
Kodiak Sciences CEO Victor Perlroth's 2018 pay jumps 616% to $5.9M
April 24, 2019